Robinhood Ventures Fund II began trading on the New York Stock Exchange today under the ticker RVII, listing at $25.00…
Adialante is working to make MRI-based cancer screening accessible beyond major hospital centers.
CellType runs agentic drug discovery on simulated human biology, letting AI agents test hypotheses before wet-lab work begins.
Robinhood Ventures Fund II backs healthcare AI startups spanning simulated drug discovery, accessible imaging, and clinical operations.
AI-biotech venture firm Dimension closes $800M third fund to invest at the intersection of computing and life sciences.
AI startup Assured raises $19M Series A to automate healthcare provider credentialing and privileging operations.
AI revenue cycle startup Candid Health triples valuation with $120M Series D round as healthcare providers double down on automation.
The AI biotech startup triples its valuation in eight months with backing from Lilly, Pfizer and Novartis partnerships.